{"id":"fluviral-influenza-vaccine-2009-2010","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site soreness or erythema"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL2109042","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains inactivated influenza virus particles or antigens from the predicted circulating strains for that season. Upon administration, it triggers both humoral (antibody) and cellular immune responses, enabling the body to recognize and neutralize the influenza virus if exposed naturally. This provides protection against infection and reduces severity of disease.","oneSentence":"Fluviral is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against the 2009-2010 seasonal influenza virus strains.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:13:07.873Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal influenza prevention, 2009-2010 season"}]},"trialDetails":[{"nctId":"NCT01022749","phase":"PHASE3","title":"Efficacy Safety Study of Flu Vaccine in Immunodepression Patients","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2009-09","conditions":"Inflammatory Bowel Disease (IBD)","enrollment":228},{"nctId":"NCT05321433","phase":"","title":"Tobacco Use and the Risk of COVID-19 and Adverse Outcomes","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2022-04-01","conditions":"COVID-19, Respiratory Tract Infections, Infections","enrollment":757585},{"nctId":"NCT01676402","phase":"PHASE1","title":"Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-08","conditions":"Influenza","enrollment":316},{"nctId":"NCT00929331","phase":"PHASE3","title":"Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-07-11","conditions":"Influenza, Human","enrollment":110},{"nctId":"NCT02415842","phase":"","title":"A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-10-26","conditions":"Immunologic Tests","enrollment":414},{"nctId":"NCT01609998","phase":"PHASE1","title":"Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-06","conditions":"Influenza","enrollment":75},{"nctId":"NCT01248208","phase":"PHASE1, PHASE2","title":"FluMist in Egg Allergic Patients","status":"COMPLETED","sponsor":"Walter Reed Army Medical Center","startDate":"2010-09","conditions":"Egg Allergy, Eligible for Vaccination Against Influenza","enrollment":17},{"nctId":"NCT00920374","phase":"PHASE3","title":"A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-06-16","conditions":"Influenza","enrollment":118},{"nctId":"NCT01811823","phase":"PHASE4","title":"Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults","status":"COMPLETED","sponsor":"University of Witwatersrand, South Africa","startDate":"2014-03-31","conditions":"Influenza, HIV, Tuberculosis","enrollment":301},{"nctId":"NCT00968890","phase":"PHASE2","title":"Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-09-12","conditions":"Influenza","enrollment":168},{"nctId":"NCT01356316","phase":"PHASE4","title":"Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Non-Elderly Adult and Elderly Subjects","status":"COMPLETED","sponsor":"Adimmune Corporation","startDate":"2010-08","conditions":"Influenza","enrollment":120},{"nctId":"NCT00888381","phase":"PHASE4","title":"A Study to Assess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy Volunteers","status":"COMPLETED","sponsor":"Seqirus","startDate":"2009-05","conditions":"Influenza","enrollment":120},{"nctId":"NCT02133781","phase":"PHASE4","title":"B-cell Immunity to Influenza (SLVP017)- Year 1, 2009","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-07","conditions":"Influenza","enrollment":51},{"nctId":"NCT00995982","phase":"PHASE1","title":"VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 Years","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2009-10-08","conditions":"Influenza, Human","enrollment":60},{"nctId":"NCT00945841","phase":"PHASE3","title":"Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010","status":"COMPLETED","sponsor":"Novartis","startDate":"2009-06","conditions":"Seasonal Influenza","enrollment":126},{"nctId":"NCT00956449","phase":"PHASE2","title":"Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects","status":"COMPLETED","sponsor":"Novartis","startDate":"2009-06","conditions":"Influenza, Seasonal Influenza","enrollment":126},{"nctId":"NCT02019732","phase":"","title":"Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-01","conditions":"Influenza","enrollment":1},{"nctId":"NCT01246999","phase":"PHASE4","title":"Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2010-10","conditions":"Influenza","enrollment":34},{"nctId":"NCT02367222","phase":"","title":"A Database Study to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix™ in Manitoba, Canada","status":"COMPLETED","sponsor":"University of Manitoba","startDate":"2014-08","conditions":"Multiple Sclerosis","enrollment":1},{"nctId":"NCT01011049","phase":"PHASE2","title":"Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2009-09","conditions":"Influenza","enrollment":1250},{"nctId":"NCT00956761","phase":"PHASE2","title":"Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010","status":"COMPLETED","sponsor":"Novartis","startDate":"2009-06","conditions":"Seasonal Influenza","enrollment":63},{"nctId":"NCT00943657","phase":"PHASE3","title":"Yearly Strain Variation Study, 2009/2010","status":"COMPLETED","sponsor":"Alachua Government Services, Inc.","startDate":"2009-06","conditions":"Influenza, Seasonal Influenza","enrollment":110},{"nctId":"NCT01063088","phase":"PHASE3","title":"Adult Safety Study of 2009/2010 Seasonal Influenza Vaccine","status":"COMPLETED","sponsor":"Alachua Government Services, Inc.","startDate":"2010-02","conditions":"Influenza","enrollment":211},{"nctId":"NCT01797029","phase":"PHASE3","title":"A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh","status":"COMPLETED","sponsor":"PATH","startDate":"2013-02","conditions":"Influenza","enrollment":1761},{"nctId":"NCT01854632","phase":"PHASE3","title":"Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal","status":"COMPLETED","sponsor":"PATH","startDate":"2013-05","conditions":"Influenza","enrollment":1761},{"nctId":"NCT01000584","phase":"PHASE4","title":"Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine","status":"COMPLETED","sponsor":"David Scheifele","startDate":"2009-11","conditions":"Influenza, H1N1 2009 Influenza","enrollment":309},{"nctId":"NCT01816464","phase":"PHASE4","title":"Immunogenicity and Safety of Trivalent Influenza Vaccine in Pregnant and Nonpregnant HIV Uninfected Women","status":"COMPLETED","sponsor":"University of Witwatersrand, South Africa","startDate":"2013-09","conditions":"Influenza","enrollment":150},{"nctId":"NCT01206114","phase":"","title":"Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11","status":"COMPLETED","sponsor":"Finnish Institute for Health and Welfare","startDate":"2010-09","conditions":"Influenza Caused by the 2009 H1N1 Influenza Virus","enrollment":2351},{"nctId":"NCT01310400","phase":"PHASE3","title":"Comparison of the Efficacy of Inflexal V With a Commercially Available Influenza Vaccine in Young Children","status":"COMPLETED","sponsor":"Crucell Holland BV","startDate":"2009-10","conditions":"Influenza","enrollment":1356},{"nctId":"NCT01579916","phase":"PHASE4","title":"A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults","status":"COMPLETED","sponsor":"MedImmune LLC","startDate":"2012-05","conditions":"Influenza","enrollment":303},{"nctId":"NCT00946179","phase":"PHASE2","title":"Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2009-05","conditions":"Influenza","enrollment":130},{"nctId":"NCT00945438","phase":"PHASE2","title":"Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intradermal Route)","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2009-05","conditions":"Influenza","enrollment":131},{"nctId":"NCT01631110","phase":"PHASE3","title":"Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains","status":"COMPLETED","sponsor":"Crucell Holland BV","startDate":"2012-07","conditions":"Influenza","enrollment":110},{"nctId":"NCT00988143","phase":"PHASE2","title":"A Study of Influenza Virus Vaccines in Children and Adults","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2009-10","conditions":"Influenza","enrollment":600},{"nctId":"NCT01812980","phase":"PHASE4","title":"Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women","status":"COMPLETED","sponsor":"University of Witwatersrand, South Africa","startDate":"2013-05","conditions":"Influenza, Human Immunodeficiency Virus","enrollment":105},{"nctId":"NCT01763060","phase":"","title":"Long Term Follow up of Patients Who Were Treated With Extracorporeal Membrane Oxygenation for Pandemic Influenza A/H1N1 Induced Severe Respiratory Failure","status":"COMPLETED","sponsor":"Karolinska University Hospital","startDate":"2012-10","conditions":"Long Term Outcome","enrollment":7},{"nctId":"NCT01306253","phase":"PHASE4","title":"A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2009/2010 Influenza Virus Strains for the Northern Hemisphere","status":"COMPLETED","sponsor":"Crucell Holland BV","startDate":"2009-06","conditions":"Influenza","enrollment":114},{"nctId":"NCT01306305","phase":"PHASE4","title":"A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere","status":"COMPLETED","sponsor":"Crucell Holland BV","startDate":"2010-06","conditions":"Influenza","enrollment":110},{"nctId":"NCT01229371","phase":"PHASE3","title":"Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers","status":"COMPLETED","sponsor":"Crucell Holland BV","startDate":"2010-10","conditions":"Influenza","enrollment":440},{"nctId":"NCT00943202","phase":"PHASE2","title":"Sanofi Pasteur, TIV + H1N1, Pediatric Population","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2009-08","conditions":"Influenza","enrollment":531},{"nctId":"NCT00934245","phase":"PHASE4","title":"Direct and Indirect Protection by Influenza Vaccine Given to Children in India","status":"COMPLETED","sponsor":"Wayne Sullender, M.D.","startDate":"2009-09","conditions":"Influenza","enrollment":4598},{"nctId":"NCT01356342","phase":"PHASE4","title":"Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Healthy Subjects Aged Over 6 Months Old to 18 Years Old","status":"COMPLETED","sponsor":"Adimmune Corporation","startDate":"2010-07","conditions":"Influenza","enrollment":181},{"nctId":"NCT00918268","phase":"PHASE2","title":"Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2009-06","conditions":"Influenza Disease","enrollment":130},{"nctId":"NCT01001325","phase":"PHASE3","title":"Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2009-10","conditions":"Influenza","enrollment":468},{"nctId":"NCT01577316","phase":"PHASE2, PHASE3","title":"Evaluate the Immunogenicity and Safety of the 2011-2012 Vaccine Against Seasonal Influenza on Pregnant Women","status":"UNKNOWN","sponsor":"Instituto Nacional de Salud Publica, Mexico","startDate":"2012-04","conditions":"Pregnancy, Investigation or Care in A Nonpregnant Woman","enrollment":240},{"nctId":"NCT01000571","phase":"","title":"Immunogenicity and Safety of Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine in Immunocompromised Children and Young Adults","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2009-10","conditions":"H1N1 Pandemic Flu","enrollment":104},{"nctId":"NCT00881842","phase":"PHASE3","title":"Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 09/10 Season","status":"COMPLETED","sponsor":"Abbott Biologicals","startDate":"2009-06","conditions":"Influenza","enrollment":120},{"nctId":"NCT01354730","phase":"","title":"A Pharmacovigilance Study for AdimFlu-S (A/H1N1) Influenza Vaccine in Pregnant Women","status":"COMPLETED","sponsor":"Adimmune Corporation","startDate":"2010-06","conditions":"Adverse Drug Reactions","enrollment":398},{"nctId":"NCT01256931","phase":"","title":"Antibody Levels Against 2009 Influenza A H1N1 One Year After Vaccination With Pandemrix and 2010 Fluarix Booster in Organ Transplant Recipients.","status":"UNKNOWN","sponsor":"Sahlgrenska University Hospital","startDate":"2010-12","conditions":"Organ Transplantation","enrollment":110},{"nctId":"NCT01235000","phase":"","title":"TIV Infant/Toddler Response Evaluation - Follow-up for Influenza B Boost","status":"UNKNOWN","sponsor":"British Columbia Centre for Disease Control","startDate":"2010-10","conditions":"Influenza","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Fluviral influenza vaccine, 2009-2010","genericName":"Fluviral influenza vaccine, 2009-2010","companyName":"Mount Sinai Hospital, Canada","companyId":"mount-sinai-hospital-canada","modality":"Biologic","firstApprovalDate":"","aiSummary":"Fluviral is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against the 2009-2010 seasonal influenza virus strains. Used for Seasonal influenza prevention, 2009-2010 season.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}